FactSet Research earnings beat by $0.09, revenue topped estimates

FactSet reported Q2 EPS of $4.46, beating the $4.37 consensus by $0.09, and revenue of $611M vs $604.62M consensus. Management guided FY2026 EPS to $17.25–$17.75 (around the $17.50 consensus) and revenue to $2.45B–$2.47B (vs $2.45B consensus). Shares closed at $204.55 and are down 29.51% over 3 months and 55.24% over 12 months; there were 4 positive and 1 negative EPS revisions in the last 90 days and InvestingPro rates the company’s financial health as "good performance."

Analysis

FactSet sits on a high-quality, recurring revenue base that amplifies even small inflections in retention and price realization; the non-obvious winner if things normalize is not only FactSet equity holders but also small data vendors whose catalogue sales reaccelerate as buy-side teams rebuild proprietary stacks. Competitive pressure from LSEG/SPGI/Bloomberg remains real, but FactSet’s lighter legacy terminal footprint and higher recent R&D spend give it disproportionate optionality to win quant and wealth-management pockets.

Primary risks are demand-led (AUM/flow compression reducing analytics spend) and structural (AI models lowering willingness to pay for curated datasets), which can surface within quarters; conversely, contract renewals and multi-year upsells are 3–12 month catalysts that can flip sentiment. A potential reversal trigger is a coordinated license-price recovery or a visible uptick in enterprise ARR growth that forces multiple re-rating, while downside tail events include significant client churn or a large competitor price war.

The market appears to price headline multiple compression more than revenue stickiness and buyback optionality — a contrarian play is to assume sticky subscription cashflows plus modest margin recovery will outpace the slow-estate derating. Second-order effects: a FactSet rebound would tighten the universe for small independent data providers (higher valuations, more M&A) and could redirect quant spend back to paid data, creating a multi-quarter bid for names across the space. Monitor renewals, net retention, and gross churn as leading indicators rather than trailing EPS beats alone.

Key Decisions for Investors

• Long FDS equity (2–4% NAV): build in 3 tranches (initial 40%, add 30/30 on 5% and 10% downside from entry). Time horizon 9–12 months; target 35–50% total return on a multiple re-rate and ARR acceleration. Hard stop 18–20% on headline churn or a material negative guide to ARR.
• FDS 12-month call spread (defined-cost alternative): buy 12-month 25%/45% OTM call spread sized to 1–2% NAV. Rationale: convex upside if a renewal cycle or buyback announcement re-rates the stock; max loss = premium, upside capped but >2x premium if re-rate occurs.
• Pair trade — long FDS / short SPGI (equal dollar, hedged exposure): 6–12 month horizon to express idiosyncratic re-rate vs incumbent. Expect outperformance if FactSet demonstrates better-than-feared retention; tear-down risk if market-wide derating continues, so size conservatively (1–2% NAV net).
• Sell cash-secured FDS puts (6–9 months, ~10% OTM): collect premium to lower effective entry and potentially accumulate at a price that assumes further short-term multiple hangover. Risk: assignment into a long position at that strike; reward: premium + optionality to own a sticky-revenue business at a discounted basis.